Gujarat Themis Stock: price and insider trades · India
1 insider bought shares over the last 90 days, the latest by Sachin D Patel, filed 27 Aug 2026.
Gujarat Themis: what insiders have been doing
This page follows insider dealings at Gujarat Themis as filed with SEBI (PIT + SAST). The last twelve months, up to 10 November 2026, brought 3 filings signed by 1 insider.
Not one open-market sale was filed. On the buying side, 1 insider reported 2 purchases. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 major shareholder.
Across the 1,984 companies tracked on its exchange, the median is 4 filings; at 3 filings, this issuer sits below that mark. Since 2026, the database holds 2 purchases and no sales by insiders of the company.
The clock since the last published purchase (27 August 2026) now reads 75 days. Publication is fast: at least half of the trades appear on SEBI (PIT + SAST) on the same day. That lag is the time during which only the insider knows about the trade.
These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 523,560 shares--SEBI:ee43c0980389587d50f51dcc8171ac6dcf83ac8eCanonical exit: 25 Nov 2026 (T+90)
- 525,000 shares-NoneSEBI:fd6a8d5699575e49d378b9f79006736171a3dc75Canonical exit: 2 Nov 2026 (T+90)
- 2,497,190 shares-Inter-se TransferSEBI:0a98f0b632adb6b959098c66cad8f5590e7128a1
3 of 3 declarations
About Gujarat Themis
Gujarat Themis is a publicly traded company on the Bombay Stock Exchange, specializing in the manufacture of pharmaceutical products. It focuses on developing innovative solutions for the healthcare sector.